Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation

被引:233
作者
Akagi, T [1 ]
Sasai, K [1 ]
Hanafusa, H [1 ]
机构
[1] Osaka Biosci Inst, Oncol Mol Lab, Suita, Osaka 5650874, Japan
关键词
D O I
10.1073/pnas.1834876100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Human cells are known to be more refractory than rodent cells against oncogenic transformation in vitro. To date, the molecular mechanisms underlying such resistance remain largely unknown. The combination of simian virus 40 early region and H-Ras V12 has been effective for transformation of rat embryo fibroblasts, but not for human cells. However, the additional ectopic expression of the telomerase catalytic subunit (hTERT) was reported to be capable of causing transformation of normal human cells. In this study, however, we demonstrate that the combined expression of the above-mentioned three genetic elements is not always sufficient to transform normal human diploid fibroblasts (HDF). Although the expression and function of these introduced genetic elements were essentially the same, among four HDF, TIG-1 and TIG-3 were resistant to transformation. The other two (BJ and IMR-90) showed transformed phenotypes, but they were much restricted compared with rat embryo fibroblasts in expressing simian virus 40 early region and H-Ras V12. In correlation with these phenotypes, TIG-1 and TIG-3 remained diploid after the introduction of these genetic elements, whereas BJ and IMR-90 became highly aneuploid. These results strongly suggest that the lack of telomerase is not the sole reason for the refractory nature of HDF against transformation and that normal human cells have still undefined intrinsic mechanisms rendering them resistant to oncogenic transformation.
引用
收藏
页码:13567 / 13572
页数:6
相关论文
共 43 条
  • [1] v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation
    Akagi, T
    Shishido, T
    Murata, K
    Hanafusa, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) : 7290 - 7295
  • [2] v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras
    Akagi, T
    Murata, K
    Shishido, T
    Hanafusa, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) : 7015 - 7023
  • [3] Cancer resistance genes in mice: models for the study of tumour modifiers
    Balmain, A
    Nagase, H
    [J]. TRENDS IN GENETICS, 1998, 14 (04) : 139 - 144
  • [4] Carcinogenesis in mouse and human cells: parallels and paradoxes
    Balmain, A
    Harris, CC
    [J]. CARCINOGENESIS, 2000, 21 (03) : 371 - 377
  • [5] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [6] A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers
    Cozma, D
    Lukes, L
    Rouse, J
    Qiu, TH
    Liu, ET
    Hunter, KW
    [J]. GENOME RESEARCH, 2002, 12 (06) : 969 - 975
  • [7] DIPAOLO JA, 1983, J NATL CANCER I, V70, P3
  • [8] Targeting ras signalling pathways in cancer therapy
    Downward, J
    [J]. NATURE REVIEWS CANCER, 2003, 3 (01) : 11 - 22
  • [9] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
    Dumont, P
    Leu, JIJ
    Della Pietra, AC
    George, DL
    Murphy, M
    [J]. NATURE GENETICS, 2003, 33 (03) : 357 - 365
  • [10] GALANG CK, 1994, ONCOGENE, V9, P2913